MiR-21-5p Modulates Cisplatin-Resistance of CD44+ Gastric Cancer Stem Cells Through Regulating the TGF-β2/SMAD Signaling Pathway
MiR-21-5p promotes cisplatin resistance in gastric cancer stem cells by regulating the TGF-β2/SMAD signalling pathway.
Authors
- Xinyang Nie
- Yuxin Teng
- Zhufeng Li (ORCID: https://orcid.org/0000-0001-9346-6245)
- Yangpu Jia (ORCID: https://orcid.org/0009-0003-9562-8553)
- Weidong Li (ORCID: https://orcid.org/0009-0007-1511-2581)
- Chuan Li (ORCID: https://orcid.org/0000-0001-5314-6618)
- Peiyao Wang (ORCID: https://orcid.org/0000-0002-8549-4075)
- Daohan Wang (ORCID: https://orcid.org/0000-0002-1646-5406)
- Li Lü (ORCID: https://orcid.org/0000-0003-0915-1588)
- Jingyu Deng (ORCID: https://orcid.org/0009-0006-3894-6995)
- Jian Liu (ORCID: https://orcid.org/0009-0009-5774-5242)
Institutions
- Tianjin Medical University General Hospital (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- International Journal of General Medicine
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/ijgm.s476647
- Citations
- 4
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 1.13